Kari R. Irvine

4.9k total citations · 1 hit paper
33 papers, 4.0k citations indexed

About

Kari R. Irvine is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Kari R. Irvine has authored 33 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 13 papers in Genetics and 12 papers in Molecular Biology. Recurrent topics in Kari R. Irvine's work include Immunotherapy and Immune Responses (26 papers), Virus-based gene therapy research (13 papers) and T-cell and B-cell Immunology (9 papers). Kari R. Irvine is often cited by papers focused on Immunotherapy and Immune Responses (26 papers), Virus-based gene therapy research (13 papers) and T-cell and B-cell Immunology (9 papers). Kari R. Irvine collaborates with scholars based in United States, Australia and Canada. Kari R. Irvine's co-authors include Nicholas P. Restifo, Steven A. Rosenberg, Bernard Moss, Miles W. Carroll, Angel Porgador, Brian H. Barber, Ronald N. Germain, Akiko Iwasaki, Jack R. Bennink and Christopher E. Touloukian and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Kari R. Irvine

33 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-specific Th17-polarized cells eradicate large established melanoma

2008 638 citations Pawel Muranski, Andrea Boni et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kari R. Irvine United States	23	3.2k	1.4k	1.1k	713	492	33	4.0k
Jean‐François Fonteneau France	33	2.7k 0.9×	1.1k 0.8×	980 0.9×	431 0.6×	530 1.1×	75	3.7k
Gayle C. Bosma United States	21	2.3k 0.7×	1.3k 0.9×	768 0.7×	562 0.8×	495 1.0×	42	4.2k
Jean‐Gérard Guillet France	36	2.5k 0.8×	1.6k 1.1×	657 0.6×	702 1.0×	688 1.4×	96	4.1k
Alice J.A.M. Sijts Netherlands	39	2.5k 0.8×	2.2k 1.6×	958 0.8×	286 0.4×	615 1.3×	83	4.3k
Yosef Refaeli United States	22	1.9k 0.6×	1.4k 1.0×	695 0.6×	333 0.5×	463 0.9×	38	3.7k
Claes Öhlén United States	28	4.0k 1.3×	657 0.5×	871 0.8×	306 0.4×	422 0.9×	50	4.6k
Lélia Delamarre United States	28	3.9k 1.2×	2.0k 1.4×	1.5k 1.3×	236 0.3×	427 0.9×	50	5.4k
Satvir S. Tevethia United States	35	2.0k 0.6×	1.1k 0.7×	1.4k 1.2×	924 1.3×	868 1.8×	129	3.9k
Jos Even France	32	3.2k 1.0×	903 0.6×	1.3k 1.2×	410 0.6×	518 1.1×	73	4.5k
Chae Gyu Park United States	34	4.2k 1.3×	1.5k 1.1×	575 0.5×	302 0.4×	540 1.1×	76	5.3k

Countries citing papers authored by Kari R. Irvine

Since Specialization

Citations

This map shows the geographic impact of Kari R. Irvine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari R. Irvine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari R. Irvine more than expected).

Fields of papers citing papers by Kari R. Irvine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kari R. Irvine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari R. Irvine. The network helps show where Kari R. Irvine may publish in the future.

Co-authorship network of co-authors of Kari R. Irvine

This figure shows the co-authorship network connecting the top 25 collaborators of Kari R. Irvine. A scholar is included among the top collaborators of Kari R. Irvine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kari R. Irvine. Kari R. Irvine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rausch, Matthew P., Kari R. Irvine, Paul A. Antony, et al.. (2010). GILT Accelerates Autoimmunity to the Melanoma Antigen Tyrosinase-Related Protein 1. The Journal of Immunology. 185(5). 2828–2835. 42 indexed citations

Muranski, Pawel, Andrea Boni, Paul A. Antony, et al.. (2008). Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood. 112(2). 362–373. 638 indexed citations breakdown →

Haeryfar, S. M. Mansour, Heather D. Hickman, Kari R. Irvine, et al.. (2008). Terminal Deoxynucleotidyl Transferase Establishes and Broadens Antiviral CD8+ T Cell Immunodominance Hierarchies. The Journal of Immunology. 181(1). 649–659. 25 indexed citations

Guo, Zong Sheng, Julie A. Hong, Kari R. Irvine, et al.. (2006). De novoInduction of a Cancer/Testis Antigen by 5-Aza-2′-Deoxycytidine Augments Adoptive Immunotherapy in a Murine Tumor Model. Cancer Research. 66(2). 1105–1113. 120 indexed citations

Pasquetto, Valérie, Huynh‐Hoa Bui, Fareed Mirza, et al.. (2005). HLA-A*0201, HLA-A*1101, and HLA-B*0702 Transgenic Mice Recognize Numerous Poxvirus Determinants from a Wide Variety of Viral Gene Products. The Journal of Immunology. 175(8). 5504–5515. 90 indexed citations

Gnant, Michael, Kari R. Irvine, Markus Puhlmann, et al.. (1999). Tumor-Specific Gene Delivery Using Recombinant Vaccinia Virus in a Rabbit Model of Liver Metastases. JNCI Journal of the National Cancer Institute. 91(20). 1744–1750. 51 indexed citations

Han, Ying, Tal Zaks, Rong‐Fu Wang, et al.. (1999). Cancer therapy using a self-replicating RNA vaccine. Nature Medicine. 5(7). 823–827. 269 indexed citations

Irvine, Kari R., et al.. (1998). Measurement of an analog of insulin-like growth factor-I in blood plasma using a novel enzyme-linked immunosorbent assay. Journal of Endocrinology. 156(3). 407–414. 2 indexed citations

Surman, Deborah R., et al.. (1998). Generation of polyclonal rabbit antisera to mouse melanoma associated antigens using gene gun immunization. Journal of Immunological Methods. 214(1-2). 51–62. 12 indexed citations

10.

Irvine, Kari R., et al.. (1997). Enhancing Efficacy of Recombinant Anticancer Vaccines With Prime/Boost Regimens That Use Two Different Vectors. JNCI Journal of the National Cancer Institute. 89(21). 1595–1601. 129 indexed citations

11.

Irvine, Kari R., et al.. (1997). Route of Immunization and the Therapeutic Impact of Recombinant Anticancer Vaccines. JNCI Journal of the National Cancer Institute. 89(5). 390–392. 15 indexed citations

12.

Irvine, Kari R., J. Babu Rao, S A Rosenberg, & Nicholas P. Restifo. (1996). Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. The Journal of Immunology. 156(1). 238–245. 203 indexed citations

13.

Rao, J. Babu, Ronald S. Chamberlain, Vincenzo Bronte, et al.. (1996). IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression. The Journal of Immunology. 156(9). 3357–3365. 115 indexed citations

14.

Irvine, Kari R., Brian J. McCabe, Steven A. Rosenberg, & Nicholas P. Restifo. (1995). Synthetic oligonucleotide expressed by a recombinant vaccinia virus elicits therapeutic CTL.. The Journal of Immunology. 154(9). 4651–4657. 37 indexed citations

15.

Irvine, Kari R. & Jeffrey Schlom. (1993). Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72. Cancer Immunology Immunotherapy. 36(5). 281–292. 10 indexed citations

16.

Kantor, Judy, Kari R. Irvine, Scott I. Abrams, et al.. (1992). Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate.. PubMed. 52(24). 6917–25. 69 indexed citations

17.

Kantor, Judy, et al.. (1992). Antitumor Activity and Immune Responses Induced by a Recombinant Carcinoembryonic Antigen-Vaccinia Virus Vaccine. JNCI Journal of the National Cancer Institute. 84(14). 1084–1091. 170 indexed citations

18.

Clark, Julia, et al.. (1979). Comparison of cynomolgus and rhesus monkey kidney cells for recovery of viruses from clinical specimens. Journal of Clinical Microbiology. 9(4). 554–556. 2 indexed citations

19.

Irvine, Kari R., et al.. (1954). Effects of Hormone Administration on Serum Protein Patterns.. Experimental Biology and Medicine. 87(2). 324–328. 7 indexed citations

20.

Irvine, Kari R., et al.. (1953). Investigation of Serum Protein Patterns in Patients Undergoing Operation. Experimental Biology and Medicine. 84(3). 707–710. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact